Carcinoma, Renal Cell: all 1,992 studies

Page 20 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.

• Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell CancerCompletedNCT00057889Phase 2
• Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell CarcinomaCompletedNCT00056173Phase 1/2
• Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00056095Phase 2
• Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerCompletedNCT00053820Phase 3
• Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerCompletedNCT00053807Phase 3
• Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney CancerCompletedNCT00050323Phase 1/2
• Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT00045370Phase 1
• PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney CancerCompletedNCT00045279Phase 2
• Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell CarcinomaCompletedNCT00044564Phase 2
• CPG 7909 in Patients Wih Stage IV Renal Cell CancerCompletedNCT00043407Phase 1/2
• PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)CompletedNCT00043368Phase 2
• Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerCompletedNCT00042965Phase 2
• BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney CancerWithdrawnNCT00040989Phase 2
• Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00039429Phase 2
• BAY 59-8862 in Treating Patients With Advanced Kidney CancerStatus unknownNCT00039169Phase 2
• Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerCompletedNCT00039052Phase 1
• Study of CP-461 in Patients With Advanced Renal Cell CancerCompletedNCT00036036Phase 2
• Survival Study Of Oncophage® vs. Observation In Patients With Kidney CancerCompletedNCT00033904Phase 3
• Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney CancerCompletedNCT00032188Phase 2
• UCN-01 in Treating Patients With Advanced or Metastatic Kidney CancerStatus unknownNCT00030888Phase 2
• Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal CancerCompletedNCT00030342Phase 1/2
• Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00027820Phase 1/2
• Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00027664Phase 2
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00027573Phase 2
• Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug ResistanceCompletedNCT00026663
• Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney CancerWithdrawnNCT00025519Phase 2
• PS-341 in Treating Patients With Metastatic Kidney CancerCompletedNCT00025376Phase 2
• Chemotherapy in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00024388Phase 2
• RPI.4610 in Treating Patients With Metastatic Kidney CancerCompletedNCT00021021Phase 2
• Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerCompletedNCT00020540Phase 1
• Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)CompletedNCT00019955Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00019539Phase 2
• flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell CancerCompletedNCT00019396Phase 2
• Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00018941Phase 3
• PS-341 in Treating Patients With Metastatic Kidney CancerCompletedNCT00017329Phase 2
• Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00016939Phase 2
• ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney CancerCompletedNCT00014183Phase 2
• Vaccine Therapy in Treating Patients With Kidney CancerTerminatedNCT00014131Phase 1
• ZD 1839 in Treating Patients With Metastatic Kidney CancerCompletedNCT00012337Phase 2
• Chemotherapy in Treating Patients With Advanced Kidney CancerCompletedNCT00011973Phase 2
• SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous TreatmentTerminatedNCT00009919Phase 2
• Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney CancerCompletedNCT00006968Phase 1/2
• Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00006864Phase 4
• Carboxyamidotriazole in Treating Patients With Metastatic Kidney CancerCompletedNCT00006486Phase 2
• Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the LungCompletedNCT00006483Phase 2
• Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNAStatus unknownNCT00006431Phase 1
• SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00006384Phase 2
• Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and MetastasesCompletedNCT00006255Phase 2
• Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
• Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWithdrawnNCT00006126Phase 1
• Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney CancerCompletedNCT00006022Phase 1
• AE-941 in Treating Patients With Metastatic Kidney CancerCompletedNCT00005995Phase 3
• Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00005966Phase 3
• Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney CancerCompletedNCT00005851Phase 1/2
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney CancerCompletedNCT00005816Phase 1
• Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
• Arsenic Trioxide in Treating Patients With Metastatic Kidney CancerCompletedNCT00005069Phase 2
• Bryostatin 1 In Treating Patients With Progressive Kidney CancerCompletedNCT00005056Phase 2
• Carboxyamidotriazole in Treating Patients With Advanced Kidney CancerCompletedNCT00005045Phase 2
• Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00005038Phase 2
• Rebeccamycin Analog in Treating Patients With Advanced Kidney CancerCompletedNCT00005027Phase 2
• Biomed 101 and Interleukin-2 in Treating Patients With Kidney CancerCompletedNCT00004890Phase 1
• Vaccine Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00004880Phase 1
• Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant MelanomaCompletedNCT00004244Phase 1
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerCompletedNCT00004135Phase 2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Bryostatin 1 in Treating Patients With Metastatic Kidney CancerCompletedNCT00003968Phase 2
• Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney CancerCompletedNCT00003928Phase 2
• Dolastatin 10 in Treating Patients With Advanced Kidney CancerCompletedNCT00003914Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Kidney CancerCompletedNCT00003683Phase 2
• Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed SurgicallyStatus unknownNCT00003664Phase 2
• Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With SurgeryStatus unknownNCT00003604Phase 2
• Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerCompletedNCT00003585Phase 1/2
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerCompletedNCT00003584Phase 2
• Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00003553Phase 2
• Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney CancerCompletedNCT00003551Phase 2
• Interferon Alfa in Treating Patients With Advanced Kidney CancerCompletedNCT00003542Phase 1/2
• Antineoplaston Therapy in Treating Patients With Stage IV Kidney CancerTerminatedNCT00003520Phase 2
• 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerCompletedNCT00003390Phase 2
• Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
• Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00003181Phase 2
• Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney CancerCompletedNCT00003126Phase 3
• High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaCompletedNCT00003091Phase 2
• Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00002847Phase 2
• Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney CancerStatus unknownNCT00002846Phase 2
• Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney CancerCompletedNCT00002737Phase 3
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00002733Phase 2
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney CancerCompletedNCT00002611Phase 3
• Lymphocyte Therapy in Treating Patients With Kidney CancerStatus unknownNCT00002589Phase 2
• Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerCompletedNCT00002473Phase 3
• A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerCompletedNCT00001683Phase 1
• A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001383Phase 1

← Carcinoma, Renal Cell overview